Cline Scientific AB (publ) (CLINE-B.ST)
Cline Scientific AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Mölndal, SE. The stock last traded at $0.07, up 0.00% on the session, giving a market capitalisation of $3.1M. Its beta of 0.37 implies it has historically moved less than the broad market.
Based in Mölndal, Sweden, Cline Scientific AB (publ), founded in 2012, is dedicated to pioneering advancements in cancer diagnostics and regenerative medical treatments. A core area of its work involves the development of an allogeneic stem cell therapy, which utilizes induced pluripotent stem (iPS) cells. The company also innovates in surface nanotechnology, applying it to cell-based products and processes to expedite life science projects into clinical development. Furthermore, Cline Scientific maintains a collaborative relationship with AstraZeneca, leveraging its gradient technology.
Cline Scientific AB (publ) is most often compared with the following Healthcare names: